Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Kim Taeyeon, Valérie Gagné‐Ouellet, Elise Duchesne, Séréna Harvey, Cynthia Gagnon, Isabelle Laforest‐Lapointe, Nicolas A. Dumont, Éric Massé
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local citing links have been materialized yet.
10.1146/annurev.neuro.29.051605.113042
10.1146/annurev.neuro.29.051605.113042
10.1126/science.1546326
10.1126/science.1546326
10.1042/bst0371281
10.1042/bst0371281
Unresolved referenced work
Kept as external metadata until matched
10.3748/wjg.v12.i12.1821
10.3748/wjg.v12.i12.1821
The prevalence of faecal incontinence in myotonic dystrophy type 1
10.1016/j.nmd.2019.05.009 · 2019
Gastrointestinal symptoms in myotonic dystrophy
10.3109/00365529609009145 · 1996
Clinical and molecular insights into gastrointestinal dysfunction in myotonic dystrophy types 1 & 2
2022
10.1212/cpj.0000000000000531
10.1212/cpj.0000000000000531
Intestinal endocrine cells in myotonic dystrophy: an immunocytochemical and computed image analytical study
10.1046/j.1365-2796.1999.00413.x · 1999
Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy
10.1097/00042737-200107000-00011 · 2001
Assessment of autonomic nerve function in myotonic dystrophy
10.1016/0165-1838(90)90144-8 · 1990
Smooth muscle involvement in primary muscle disease. I. Myotonic dystrophy
1967
Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable
10.1002/mus.21787 · 2010
Mechanisms of diarrhoea in myotonic dystrophy
10.1097/00042737-199807000-00015 · 1998
10.1126/scitranslmed.aan5662
10.1126/scitranslmed.aan5662
10.1016/j.ajpath.2023.10.010
10.1016/j.ajpath.2023.10.010
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice
10.15252/emmm.202216244 · 2023
DM1 Transgenic Mice Exhibit Abnormal Neurotransmitter Homeostasis and Synaptic Plasticity in Association with RNA Foci and Mis-Splicing in the Hippocampus
10.3390/ijms23020592 · 2022
Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy
2022
Mbnl1 and Mbnl2 regulate brain structural integrity in mice
10.1038/s42003-021-02845-0 · 2021
10.1016/j.omtm.2021.09.007
10.1016/j.omtm.2021.09.007
10.1002/chem.201804368
10.1002/chem.201804368
10.1074/jbc.m115.710616
10.1074/jbc.m115.710616
10.1016/j.celrep.2015.11.028
10.1016/j.celrep.2015.11.028
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
10.3390/ijms23094622 · 2022
Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients
10.1113/jp282725 · 2022
10.1038/s41551-021-00838-2
10.1038/s41551-021-00838-2
10.1016/j.drudis.2018.08.004
10.1016/j.drudis.2018.08.004
10.1016/j.csbj.2024.05.009
10.1016/j.csbj.2024.05.009
10.1371/journal.pgen.1003043
10.1371/journal.pgen.1003043
Gut microbiota determines the social behavior of mice and induces metabolic and inflammatory changes in their adipose tissue
10.1038/s41522-021-00193-9 · 2021
10.1186/s40168-014-0050-9
10.1186/s40168-014-0050-9
Potential interaction between timing of infant complementary feeding and breastfeeding duration in determination of early childhood gut microbiota composition and BMI
10.1111/ijpo.12642 · 2020
10.1186/s12866-020-01724-8
10.1186/s12866-020-01724-8
10.1038/ismej.2012.8
10.1038/ismej.2012.8
10.1128/aem.01043-13
10.1128/aem.01043-13
10.1038/nmeth.3869
10.1038/nmeth.3869
10.1371/journal.pone.0061217
10.1371/journal.pone.0061217
Unresolved referenced work
Kept as external metadata until matched
10.1038/s41593-022-01027-3
10.1038/s41593-022-01027-3 · doi-reference
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
10.15252/emmm.202216225 · doi-reference
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
10.1002/ibd.22839 · doi-reference
10.4049/jimmunol.1601410
10.4049/jimmunol.1601410 · doi-reference
10.1189/jlb.0103024
10.1189/jlb.0103024 · doi-reference
Expression of chemokine CCL20 in ulcerative colitis
10.3892/mmr.2012.1088 · doi-reference
CCR6–CCL20 Axis in IBD: What Have We Learnt in the Last 20 Years?
10.3390/gidisord1010006 · doi-reference
C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release
10.3390/ijms19103257 · doi-reference
10.1038/mi.2008.84
10.1038/mi.2008.84 · doi-reference
10.1111/odi.13843
10.1111/odi.13843 · doi-reference
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
10.1038/s41598-019-49462-w · doi-reference
Gut Microbiome of Indonesian Adults Associated with Obesity and Type 2 Diabetes: A Cross-Sectional Study in an Asian City, Yogyakarta
10.3390/microorganisms9050897 · doi-reference
Romboutsia lituseburensis JCM1404 supplementation ameliorated endothelial function via gut microbiota modulation and lipid metabolisms alterations in obese rats
10.1093/femsle/fnad016 · doi-reference
10.1016/j.foodres.2021.110530
10.1016/j.foodres.2021.110530 · doi-reference
Lycium barbarum polysaccharide attenuates myocardial injury in high-fat diet-fed mice through manipulating the gut microbiome and fecal metabolome
10.1016/j.foodres.2020.109778 · doi-reference
Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders
10.1177/1756284820971201 · doi-reference
Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia
10.3390/microorganisms7080228 · doi-reference
10.1097/meg.0000000000000542
10.1097/meg.0000000000000542 · doi-reference
Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer
10.1038/srep04202 · doi-reference
Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis—Deepening Heterogeneity for a Personalized Therapy
10.3390/ijms21249735 · doi-reference
C-X-C Motif Chemokine Ligand 1 Promotes Colitis by Modulating the Gut Microbiota
10.1159/000535637 · doi-reference
10.1023/b:joci.0000018066.46279.6b
10.1023/b:joci.0000018066.46279.6b · doi-reference
10.1038/163688a0
10.1038/163688a0 · doi-reference
10.1002/j.1538-7305.1948.tb01338.x
10.1002/j.1538-7305.1948.tb01338.x · doi-reference
10.1093/nar/gks1219
10.1093/nar/gks1219 · doi-reference